JME
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Accepted Preprint first posted online on 29 December 2008

Journal of Molecular Endocrinology 2009;42:269.

Journal of Molecular Endocrinology (2008) In press  DOI: 10.1677/JME-08-0142
© 2008 Society for Endocrinology

This Article
Right arrow Accepted manuscript (PDF)
Right arrow All Versions of this Article:
JME-08-0142v1
42/4/269    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bassett, D.
Right arrow Articles by Williams, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bassett, D.
Right arrow Articles by Williams, G.

Review

The skeletal phenotypes of TRalpha and TRbeta mutant mice.

Duncan Bassett and Graham Williams

D Bassett, Metabolic Medicine, Imperial College London, London, W12 0NN, United Kingdom
G Williams, Molecular Endocrinology Group, Imperial College London, London, United Kingdom

Correspondence: Duncan Bassett, Email: d.bassett{at}imperial.ac.uk

Abstract

Analysis of mice harbouring deletions or mutations of thyroid hormone receptor {alpha} (TR{alpha}) and β (TRβ) have clarified the complex relationship between central and peripheral thyroid status and emphasised the essential but contrasting roles of thyroid hormone (T3) in skeletal development and adult bone. These studies indicate that TR{alpha}1 is the predominant TR expressed in bone and that T3 exerts anabolic actions during growth but catabolic actions in the adult skeleton. Examination of key skeletal regulatory pathways in TR mutant mice has identified growth hormone, insulin like growth factor 1 and fibroblast growth factor signalling and the Indian hedgehog/parathyroid hormone-related peptide feed back loop as major targets of T3 action in chondrocytes and osteoblasts. Nevertheless, although increased osteoclastic resorption is a major feature of thyrotoxic bone loss and altered osteoclast activity is central to the skeletal phenotype of TR mutant mice, it remains unclear whether T3 has direct actions in osteoclasts. Detailed future analysis of the molecular mechanisms of T3 action in bone will enhance our understanding of this emerging field and has the potential to identify novel strategies for prevention and treatment of osteoporosis.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Endocrinology.